• 1
    Phillips KA, Bernhard J. Adjuvant breast cancer treatment and cognitive function: current knowledge and research directions. J Natl Cancer Inst. 2003; 95: 190197.
  • 2
    Wefel JS, Lenzi R, Theriault R, Buzdar AU, Cruickshank S, Meyers CA. ‘Chemobrain’ in breast carcinoma? A prologue. Cancer. 2004; 101: 466475.
  • 3
    Jansen CE, Miaskowski C, Dodd M, Dowling G, Kramer J. A metaanalysis of studies of the effects of cancer chemotherapy on various domains of cognitive function. Cancer. 2005; 104: 22222233.
  • 4
    Falleti MG, Sanfilippo A, Maruff P, Weih L, Phillips KA. The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature. Brain Cogn. 2005; 59: 6070.
  • 5
    Anderson-Hanley C, Sherman ML, Riggs R, Agocha VB, Compas BE. Neuropsychological effects of treatments for adults with cancer: a meta-analysis and review of the literature. J Int Neuropsychol Soc. 2003; 9: 967982.
  • 6
    Matsuda T, Takayama T, Tashiro M, Nakamura Y, Ohashi Y, Shimozuma K. Mild cognitive impairment after adjuvant chemotherapy in breast cancer patients-evaluation of appropriate research design and methodology to measure symptoms. Breast Cancer. 2005; 12: 279287.
  • 7
    Tuxen MK, Hansen SW. Neurotoxicity secondary to antineoplastic drugs. Cancer Treat Rev. 1994; 20: 191214.
  • 8
    Troy L, McFarland K, Littman-Power S, et al. Cisplatin-based therapy: a neurological and neuropsychological review. Psychooncology. 2000; 9: 2939.
  • 9
    Choi SM, Lee SH, Yang YS, Kim BC, Kim MK, Cho KH. 5-fluorouracil-induced leukoencephalopathy in patients with breast cancer. J Korean Med Sci. 2001; 16: 328334.
  • 10
    Saykin AJ, Ahles TA, McDonald BC. Mechanisms of chemotherapy-induced cognitive disorders: neuropsychological, pathophysiological, and neuroimaging perspectives. Semin Clin Neuropsychiatry. 2003; 8: 201216.
  • 11
    Rugo HS, Ahles T. The impact of adjuvant therapy for breast cancer on cognitive function: current evidence and directions for research. Semin Oncol. 2003; 30: 749762.
  • 12
    Madhyastha S, Somayaji SN, Rao MS, Nalini K, Bairy KL. Hippocampal brain amines in methotrexate-induced learning and memory deficit. Can J Physiol Pharmacol. 2002; 80: 10761084.
  • 13
    van der Kooy D, Zito KA, Roberts DC. Evidence on the retrograde neurotoxicity of doxorubicin. Neurosci Lett. 1985; 53: 215219.
  • 14
    Rzeski W, Pruskil S, Macke A, et al. Anticancer agents are potent neurotoxins in vitro and in vivo. Ann Neurol. 2004; 56: 351360.
  • 15
    Joshi G, Sultana R, Tangpong J, et al. Free radical mediated oxidative stress and toxic side effects in brain induced by the anti cancer drug adriamycin: insight into chemobrain. Free Radic Res. 2005; 39: 11471154.
  • 16
    Yoshikawa E, Matsuoka Y, Inagaki M, et al. No adverse effects of adjuvant chemotherapy on hippocampal volume in Japanese breast cancer survivors. Breast Cancer Res Treat. 2005; 92: 8184.
  • 17
    Ahles TA, Saykin AJ, Furstenberg CT, et al. Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. J Clin Oncol. 2002; 20: 485493.
  • 18
    Fan HG, Houede-Tchen N, Yi QL, et al. Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study. J Clin Oncol. 2005; 23: 80258032.
  • 19
    Schagen SB, Muller MJ, Boogerd W, et al. Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients. Ann Oncol. 2002; 13: 13871397.
  • 20
    Wefel JS, Lenzi R, Theriault RL, Davis RN, Meyers CA. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial. Cancer. 2004; 100: 22922299.
  • 21
    Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12: 189198.
  • 22
    Mori E, Mitani Y, Yamadori A. [ Usefulness of a Japanese version of the Mini-Mental State in neurological patients]. (Japanese). Shinkeishinrigaku. 1985; 1: 8290.
  • 23
    Sapolsky RM. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry. 2000; 57: 925935.
  • 24
    Wechsler D. Wechsler Memory Scale-Revised. New York: Psychological Corp; 1987.
  • 25
    Sugishita M. Wechsler Memory Scale-Revised (Japanese). Tokyo: Nihonbunkakagakusya; 2001.
  • 26
    Omura K, Sugishita M. Simultaneous confirmatory factor analysis of the Wechsler memory scale – revised for two standardization samples: a comparison of groups from Japan and the United States. J Clin Exp Neuropsychol. 2004; 26: 645652.
  • 27
    Ashburner J, Friston KJ. Voxel-based morphometry-the methods. Neuroimage. 2000; 11(6 pt 1): 805821.
  • 28
    Good CD, Johnsrude IS, Ashburner J, Henson RN, Friston KJ, Frackowiak RS. A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage. 2001; 14(1 pt 1): 2136.
  • 29
    Good CD, Johnsrude I, Ashburner J, Henson RN, Friston KJ, Frackowiak RS. Cerebral asymmetry and the effects of sex and handedness on brain structure: a voxel-based morphometric analysis of 465 normal adult human brains. Neuroimage. 2001; 14: 685700.
  • 30
    Ashburner J, Neelin P, Collins DL, Evans A, Friston K. Incorporating prior knowledge into image registration. Neuroimage. Nov 1997; 6: 344352.
  • 31
    Ashburner J, Friston KJ. Nonlinear spatial normalization using basis functions. Hum Brain Mapp. 1999; 7: 254266.
  • 32
    Worsley KJ, Marrett S, Neelin P, Vandal AC, Friston KJ, Evans AC. A unified statistical approach for determining significant voxels in images of cerebral activation. Hum Brain Mapp. 1996; 4: 5873.
  • 33
    Friston KJ, Holmes A, Poline JB, Price CJ, Frith CD. Detecting activations in PET and fMRI: levels of inference and power. Neuroimage. Dec 1996; 4(3 pt 1): 223235.
  • 34
    Brett M, Johnsrude IS, Owen AM. The problem of functional localization in the human brain. Nat Rev Neurosci. 2002; 3: 243249.
  • 35
    Petrides M. Mapping prefrontal cortical systems for the control of cognition. In: TogaAW, MazziottaJC, eds. Brain mapping: the systems. 1st ed. New York: Academic Press; 2000: 159176.
  • 36
    Witter MP, Wouterlood F. Parahippocampal region: organization and role in cognitive functions. New York and London: Oxford University Press; 2002.
  • 37
    Cavanna AE, Trimble MR. The precuneus: a review of its functional anatomy and behavioural correlates. Brain. 2006; 129(pt 3): 564583.